Abstract
TB remains a critical public health problem worldwide. Near point-of-care (NPOC) non-sputum-based tests can potentially provide more accessible TB diagnosis and reduce delays. EVIDENT cluster randomised controlled trial (cRCT) is part of a larger series of studies within the EVIDENT Research Project in Indonesia. Based on a clinical validation study (EVIDENT work package 1) and a diagnostic yield, feasibility, and cost study (EVIDENT work package 2), the cRCT (EVIDENT work package 3) will provide evidence of the effects of implementing a multi-component public health intervention in the intervention arm, compared to the control arm. We provide the EVIDENT WP3 trial protocol, supplementary files, and the SPIRIT 2025 Checklist as extended data and reporting guidelines on this platform.